Diets
A1 beta-casein worsens gastrointestinal symptoms
In plain terms: Does regular (A1) milk upset your stomach more than A2 milk?
Leans support Diets 💰 Industry COI noted🔬 Includes disconfirming
Part of: 🧪 a1 beta-casein
RefutedContestedStrong support
consensus score 0.32
Yes — but much of the supporting evidence comes from A2-milk marketers, so weigh that conflict of interest.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
13 support 1 contradict 5 tested null 7 mixed · 26 sources, 12 independent groups
What the evidence shows
Whether A1 (vs A2) beta-casein worsens GI symptoms is CONTESTED and confounded: the positive trials are funded by the a2 Milk Company, while the best independent/objective-endpoint trials are null or find symptoms track LACTOSE, not casein type. A real distinct 'A1 intolerance' in lactose-tolerant people is not established.
The evidence (26)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Yu W et al 2025 · study_type: RCT | RCT | supports | low | RCT in 180 toddlers (A1-protein-free vs conventional formula, 90 days): ARI/diarrhea relative risk did NOT differ significantly between groups, but ARI duration was shorter (3 vs 5 days, p=0.012) and bloating/gassiness/regurgitation were le |
| Li J et al 2025 · study_type: RCT | RCT | supports | moderate | RCT in 280 Chinese infants (n=140/arm): A1-beta-casein-free formula (A1PF) had significantly lower IGSQ total/stooling/spitting-vomiting/crying/fussiness scores and fewer crying episodes vs conventional (A1+A2) formula at weeks 2 and 4 (p<0 |
| Borş A et al 2024 · study_type: observational | observational | mixed | low | Narrative review stating A2 milk 'may have potential health benefits' but explicitly notes 'few clinical studies have been conducted in humans, and the results have been unsatisfactory,' urging caution interpreting the literature. |
| Cieślińska A et al 2022 · study_type: observational | observational | supports | low | Review update: 'newest clinical studies on humans showed a negative effect of variant A1 on serum glutathione level, digestive well-being, cognitive performance score in children, and mood score in women,' while calling for more well-design |
| Ramakrishnan 2023 · Nutrients | RCT | tested-null | low | MRI crossover: A1+A2 milk emptied faster from stomach and raised abdominal pain vs A2-only in lactose maldigesters. |
| Liu 2022 · Frontiers in Nutrition | animal | supports | low | A2-only milk improved villus/crypt morphology and gut immune/SCFA profile vs A1A2 milk in mice. |
| Greenway F, et al. 2026 · (crossover) | RCT | tested-null | low | RCT w/ objective SmartPill transit: NO difference A1-free vs conventional |
| Jeong H et al 2024 · study_type: observational | observational | mixed | low | Narrative review: cites animal studies showing A1 beta-casein increases digestive transit time and myeloperoxidase activity, and states BCM-7 'can lead to inflammation and discomfort in sensitive individuals'; also repeats unproven links to |
| Jianqin S, et al. 2016 · Nutr J | RCT | supports | moderate | A2-only milk vs A1+A2 reduced PD3 GI discomfort, inflammation markers and worsened cognition in self-reported lactose-intolerant subjects. ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
| Ali AH et al 2026 · study_type: observational | observational | supports | low | Narrative review of βCM-7 (the A1-derived opioid peptide): notes potential advantages on immune/GI health but also 'concerns persist regarding its adverse effects' — no quantitative synthesis given in abstract. |
| Sheng XY et al 2024 · study_type: RCT | RCT | mixed | low | RCT (n=120 infants + 60 breastfed comparator, 4 months): A2 beta-casein formula (with added CPP/palmitate) showed softer stool, more frequent stooling, less abdominal distention/burp/flatus, less constipation, and fewer adverse events vs co |
| Meng 2023 · Nutrients | RCT | mixed | low | A2-only growing-up milk improved digestive comfort/GI tolerance vs conventional milk in toddlers (China RCT). |
| Kamiński S et al 2025 · study_type: observational | observational | tested-null | low | Analytical study quantifying A1 and BCM-7 in raw/processed milk (ELISA); A1 variant more abundant than A2 in samples, but BCM-7 levels 'did not vary significantly with CSN2 genotype or processing method' — no GI symptom data collected. |
| Robinson LA et al 2025 · study_type: RCT | RCT | tested-null | moderate | 5-week double-blind crossover RCT (n=48) comparing lactose-free conventional milk (A1-containing), A2 milk, and lactose-free A2 milk; overall symptoms minimal, but A2 milk had LOWER bloating/flatulence than lactose-free A2 on some days, and |
| Choi Y et al 2024 · study_type: RCT | RCT | mixed | moderate | Double-blind crossover RCT (n=40, GI-discomfort-prone Koreans): A2 milk INCREASED bloating (p=0.041) and loose stools (p=0.026) vs A1/A2 milk on GSRS, but caused LESS abdominal pain (p=0.05), fecal urgency (p<0.001), and borborygmus (p=0.00 |
| Song CH et al 2025 · study_type: RCT | RCT | supports | low | RCT/crossover (n=35, GI-discomfort-prone South Koreans): A2-only milk shifted gut microbiota beta diversity significantly (p=0.04) with increases in beneficial Bifidobacterium/Blautia vs no significant shift after A1/A2 milk; endpoint is mi |
| Ramakrishnan 2020 · Nutrients | RCT | mixed | low | Single-meal crossover: A2-only milk gave lower abdominal pain scores than conventional A1+A2 milk in lactose-intolerant subjects. |
| Barnett 2014 · Int J Food Sci Nutr | animal | supports | moderate | A1 diet raised GI transit time, colonic myeloperoxidase and jejunal DPP-4 vs A2 in rats; opioid-dependent and -independent effects. |
| Fernández-Rico S et al 2022 · study_type: observational | observational | supports | low | Review noting A2 milk releases much smaller amounts of BCM-7 'linked to harmful effects on human health' but frames this as an industry/technology update without independent quantitative synthesis of GI symptom trial data. |
| Brooke-Taylor 2017 · Adv Nutr | observational | supports | moderate | Systematic review of 39 studies: A1 delays intestinal transit and triggers inflammation (rodents) and looser stool/discomfort (humans) vs A2. |
| Ul Haq 2014 · Eur J Nutr | animal | supports | moderate | A1-containing milk feeding induced Th2-mediated gut inflammatory response in mice vs A2A2. |
| Gao X et al 2025 · study_type: animal | animal | tested-null | low | Mouse study (n=32, 4 groups gavaged with A2, A1/A2, A1 milk, or saline x5wk): A2 group showed increased goblet cell number and occludin expression (barrier markers) in colon vs other groups; gut microbiota/metabolite differences also seen b |
| He M, et al. 2017 · Nutr J | RCT | supports | low | n=600 RCT: A1/A2 milk -> higher GI symptom scores vs A2-only (a2 Milk Company funded) |
| Escobar-Charry MA et al 2026 · Journal of Dairy Science | in-vitro | mixed | moderate | In vitro INFOGEST digestion model of Colombian commercial milks: BCM-7 release from A1/A2 casein varies by geographic origin/phase (gastric release 5-50 ng/mL, intestinal release 30-1050 ng/mL) — a compositional/kinetic study, no symptom or |
| Sheng X, et al. 2019 · (children) | RCT | supports | moderate | A2-only milk reduced GI symptoms of milk intolerance vs conventional milk in Chinese preschoolers, with cognitive gains. |
| Mannila M, et al. 2025 · (crossover) | RCT | contradicts | moderate | Genotype-stratified RCT: symptoms tracked LACTOSE; A1/A2 difference vanished once lactose controlled |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.